has_radio_last_6_months
Metadata
- Coding system
- OPCS-4
- Coding system release
- unknown
- Organisation
- QCovid
- Codelist ID
- qcovid/has_radio_last_6_months
- Version ID
- 6732f71c
- Number of codes included
- 82
About
Description
OPCS codelist for the `has_radio_last_6_months` group in the QCovid® to develop the
        COVID-19 Population Risk Assessment.
References
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
| code | term | 
|---|---|
| A613 | Radiotherapy to lesion of peripheral nerve | 
| C395 | Radiotherapy to lesion of conjunctiva | 
| C823 | External beam radiotherapy to lesion of retina | 
| C824 | Plaque radiotherapy to lesion of retina | 
| J123 | Selective internal radiotherapy with microspheres to lesion of liver | 
| M706 | Radioactive seed implantation into prostate | 
| M712 | Implantation of radioactive substance into prostate | 
| P205 | Implantation of radioactive substance into vagina | 
| Q151 | Introduction of radioactive substance into uterine cavity | 
| X65 | Radiotherapy delivery | 
| X651 | Delivery of a fraction of total body irradiation | 
| X652 | Delivery of a fraction of intracavitary radiotherapy | 
| X653 | Delivery of a fraction of interstitial radiotherapy | 
| X654 | Delivery of a fraction of external beam radiotherapy NEC | 
| X655 | Oral delivery of radiotherapy for thyroid ablation | 
| X656 | Delivery of a fraction of intraluminal brachytherapy | 
| X657 | Delivery of radionuclide therapy NEC | 
| X658 | Other specified radiotherapy delivery | 
| X659 | Unspecified radiotherapy delivery | 
| Y35 | Introduction of removable radioactive material into organ NOC | 
| Y351 | Introduction of radioactive caesium into organ NOC | 
| Y352 | Introduction of iridium wire into organ NOC | 
| Y353 | Introduction of radium into organ NOC | 
| Y354 | Introduction of radioactive substance into organ for brachytherapy NOC | 
| Y358 | Other specified introduction of removable radioactive material into organ NOC | 
| Y359 | Unspecified introduction of removable radioactive material into organ NOC | 
| Y36 | Introduction of non-removable material into organ NOC | 
| Y361 | Introduction of gold seeds into organ NOC | 
| Y362 | Introduction of therapeutic implant into organ NOC | 
| Y363 | Radioactive seed implantation NOC | 
| Y364 | Introduction of non-removable radioactive substance into organ for brachytherapy NOC | 
| Y368 | Other specified introduction of non-removable material into organ NOC | 
| Y369 | Unspecified introduction of non-removable material into organ NOC | 
| Y91 | External beam radiotherapy | 
| Y911 | Megavoltage treatment for complex radiotherapy | 
| Y912 | Megavoltage treatment for simple radiotherapy | 
| Y913 | Superficial or orthovoltage treatment for radiotherapy | 
| Y914 | Megavoltage treatment for adaptive radiotherapy | 
| Y915 | Megavoltage treatment for hypofractionated stereotactic radiotherapy | 
| Y918 | Other specified external beam radiotherapy | 
| Y919 | Unspecified external beam radiotherapy | 
| A613 | Radiotherapy to lesion of peripheral nerve | 
| C395 | Radiotherapy to lesion of conjunctiva | 
| C823 | External beam radiotherapy to lesion of retina | 
| C824 | Plaque radiotherapy to lesion of retina | 
| J123 | Selective internal radiotherapy with microspheres to lesion of liver | 
| M706 | Radioactive seed implantation into prostate | 
| M712 | Implantation of radioactive substance into prostate | 
| P205 | Implantation of radioactive substance into vagina | 
| Q151 | Introduction of radioactive substance into uterine cavity | 
| X65 | Radiotherapy delivery | 
| X651 | Delivery of a fraction of total body irradiation | 
| X652 | Delivery of a fraction of intracavitary radiotherapy | 
| X653 | Delivery of a fraction of interstitial radiotherapy | 
| X654 | Delivery of a fraction of external beam radiotherapy NEC | 
| X655 | Oral delivery of radiotherapy for thyroid ablation | 
| X656 | Delivery of a fraction of intraluminal brachytherapy | 
| X657 | Delivery of radionuclide therapy NEC | 
| X658 | Other specified radiotherapy delivery | 
| X659 | Unspecified radiotherapy delivery | 
| Y35 | Introduction of removable radioactive material into organ NOC | 
| Y351 | Introduction of radioactive caesium into organ NOC | 
| Y352 | Introduction of iridium wire into organ NOC | 
| Y353 | Introduction of radium into organ NOC | 
| Y354 | Introduction of radioactive substance into organ for brachytherapy NOC | 
| Y358 | Other specified introduction of removable radioactive material into organ NOC | 
| Y359 | Unspecified introduction of removable radioactive material into organ NOC | 
| Y36 | Introduction of non-removable material into organ NOC | 
| Y361 | Introduction of gold seeds into organ NOC | 
| Y362 | Introduction of therapeutic implant into organ NOC | 
| Y363 | Radioactive seed implantation NOC | 
| Y364 | Introduction of non-removable radioactive substance into organ for brachytherapy NOC | 
| Y368 | Other specified introduction of non-removable material into organ NOC | 
| Y369 | Unspecified introduction of non-removable material into organ NOC | 
| Y91 | External beam radiotherapy | 
| Y911 | Megavoltage treatment for complex radiotherapy | 
| Y912 | Megavoltage treatment for simple radiotherapy | 
| Y913 | Superficial or orthovoltage treatment for radiotherapy | 
| Y914 | Megavoltage treatment for adaptive radiotherapy | 
| Y915 | Megavoltage treatment for hypofractionated stereotactic radiotherapy | 
| Y918 | Other specified external beam radiotherapy | 
| Y919 | Unspecified external beam radiotherapy |